Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan Fu

Showing results (241-250 of 266) with videos related to

Pageof 27
Sort By:
Experimental Hematology & Oncology|January 3, 2025
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemiaTingting Yang, Yetian Dong, Mingming Zhang, et al.
HLA|May 15, 2026
CD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for Anti-HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical StudyHaiqiong Zheng, Houli Zhao, Xinyi Zhu, et al.
Frontiers in Endocrinology|August 22, 2025
Association of the atherogenic index of plasma and high-sensitivity C-reactive protein with incident cardiovascular disease: evidence from a national cohort of middle-aged and older Chinese adultsPing-An Lian, Fei Xie, Wei Zhang, et al.
Leukemia|July 3, 2026
CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemiaMingming Zhang, Lianxuan Liu, Shan Fu, et al.
Oncotarget|January 7, 2017
Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapyXin Wang, Yuan Tian, Yuan Tang, et al.
International Journal of Rheumatic Diseases|November 7, 2018
High prevalence and correlates of osteoporosis in men aged 50  years and over: A nationwide osteoporosis survey in TaiwanChi-Hua Ko, Shan-Fu Yu, Fu-Mei Su, et al.
Leukemia & Lymphoma|June 8, 2013
Rapamycin interacts synergistically with idarubicin to induce T-leukemia cell apoptosis in vitro and in a mesenchymal stem cell simulated drug-resistant microenvironment via Akt/mammalian target of rapamycin and extracellular signal-related kinase signaling pathwaysKang-Ni Wu, Yan-Min Zhao, Ying He, et al.
Frontiers in Immunology|January 6, 2022
Different Effects of Biologics on Systemic Bone Loss Protection in Rheumatoid Arthritis: An Interim Analysis of a Three-Year Longitudinal Cohort StudyMing-Han Chen, Shan-Fu Yu, Jia-Feng Chen, et al.
Therapeutic Advances in Chronic Disease|March 3, 2022
Establishment of a preliminary FRAX®-based intervention threshold for rheumatoid arthritis-associated fragility fracture: a 3-year longitudinal, observational, cohort studyShan-Fu Yu, Ming-Han Chen, Jia-Feng Chen, et al.
Environment International|June 14, 2011
Determination of polybrominated diphenyl ethers in human semenPeng-Yan Liu, Ya-Xian Zhao, Yi-Yang Zhu, et al.
Pageof 27

Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
Experimental Hematology & Oncology|January 3, 2025
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemiaTingting Yang, Yetian Dong, Mingming Zhang, et al.
HLA|May 15, 2026
CD19/BCMA-Targeted Chimeric Antigen Receptor-T Cell Therapy for Anti-HLA Antibody Sensitisation in Patients With Acute Leukaemia: A Pilot Clinical StudyHaiqiong Zheng, Houli Zhao, Xinyi Zhu, et al.
Frontiers in Endocrinology|August 22, 2025
Association of the atherogenic index of plasma and high-sensitivity C-reactive protein with incident cardiovascular disease: evidence from a national cohort of middle-aged and older Chinese adultsPing-An Lian, Fei Xie, Wei Zhang, et al.
Leukemia|July 3, 2026
CD7 chimeric antigen receptor T cells in patients with relapsed or refractory CD7-positive acute myeloid leukemiaMingming Zhang, Lianxuan Liu, Shan Fu, et al.
Oncotarget|January 7, 2017
Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapyXin Wang, Yuan Tian, Yuan Tang, et al.
International Journal of Rheumatic Diseases|November 7, 2018
High prevalence and correlates of osteoporosis in men aged 50  years and over: A nationwide osteoporosis survey in TaiwanChi-Hua Ko, Shan-Fu Yu, Fu-Mei Su, et al.
Leukemia & Lymphoma|June 8, 2013
Rapamycin interacts synergistically with idarubicin to induce T-leukemia cell apoptosis in vitro and in a mesenchymal stem cell simulated drug-resistant microenvironment via Akt/mammalian target of rapamycin and extracellular signal-related kinase signaling pathwaysKang-Ni Wu, Yan-Min Zhao, Ying He, et al.
Frontiers in Immunology|January 6, 2022
Different Effects of Biologics on Systemic Bone Loss Protection in Rheumatoid Arthritis: An Interim Analysis of a Three-Year Longitudinal Cohort StudyMing-Han Chen, Shan-Fu Yu, Jia-Feng Chen, et al.
Therapeutic Advances in Chronic Disease|March 3, 2022
Establishment of a preliminary FRAX®-based intervention threshold for rheumatoid arthritis-associated fragility fracture: a 3-year longitudinal, observational, cohort studyShan-Fu Yu, Ming-Han Chen, Jia-Feng Chen, et al.
Environment International|June 14, 2011
Determination of polybrominated diphenyl ethers in human semenPeng-Yan Liu, Ya-Xian Zhao, Yi-Yang Zhu, et al.
Pageof 27